‌

US Patent 8496938 Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

Patent 8496938 was granted and assigned to Vaccinex, Inc on July, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Vaccinex, Inc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

84969380

Date of Patent

July 30, 2013

Patent Application Number

127761870

Date Filed

May 7, 2010

Patent Citations Received

‌

US Patent 11655282 Chimeric engulfment receptor molecules

‌

US Patent 12006365 Human anti-semaphorin 4D antibody

‌

US Patent 11708423 Chimeric engulfment receptor molecules and methods of use

‌

US Patent 11660330 Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy

Patent Primary Examiner

‌

Gerald R Ewoldt

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8496938 Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API